"Right now, there is no Chinese company among the top 50 in the biopharmaceutical industry, but I'm absolutely certain that this is going to change," said German Merck's Chair and CEO, Stefan Oschmann, PhD. Dr. Oschmann was speaking to CNBC reporters at the Davos Conference (see story). He also believes that
Stock Symbol: (Xetra: MRK)
Share this with colleagues:
Original Article: Merck CEO: China Will Have a Top 50 Biopharma Company